HIV pill Truvada that cuts risk of infection among gay men by 86%

A daily HIV pill that can dramatically cut a person’s risk of contracting the disease must be made available through the NHS “as soon as possible”, campaigners have said.

Results of a major UK trial of pre-exposure prophylaxis (PrEP) have been described as “extremely exciting” and a “game-changer” by leading specialists.

The Proud study found that PrEP cut the risk of HIV infection among gay men considered to be at high risk by an unprecedented 86 per cent.

HIV pill Truvada that cuts risk of infection among gay men by 86%

A daily HIV pill that can dramatically cut a person’s risk of contracting the disease must be made available through the NHS “as soon as possible”, campaigners have said.

LGBTQ+ pioneers in healthcare leading the charge for inclusivity in the NHS

Following the storm of racism, the EEAST will hear about LGBTQ+ experiences.

In Tennessee, a fight over LGBTQ rights threatens access to HIV care

HIV rates doubled in Ireland over past 12 months

New Zealand : Report Backs New Blood Donation Rules

WHO has confirmed the first case of sexual transmission of Mpox in Congo during a large outbreak

Mpox infections have been reported for the first time since the spring In Ireland, but Covid cases are decreasing

Rainbow Knowledge survey sheds light on mental health challenges encountered by Indigenous LGBTIQA+ adolescents, according to Walkern Katatdjin

A daily HIV pill that can dramatically cut a person’s risk of contracting the disease must be made available through the NHS “as soon as possible”, campaigners have said.

Related Stories

You May Also Like

Follow us